In cell experiments, GLP-1 was found to have more mechanisms that may inhibit liver fat synthesis, such as FAM3A, NRF2, NaB, SHP1/AMPK, NLRP3, FGF21, IRS2, and other signaling pathways, which also provided direct evidence for the role of GLP-1R in the regulation of lipid metabolism in the liver
This significant unmet clinical need underscores the urgency for developing adjunctive or alternative neuroprotective strategies
Simultaneously, the loss of interest in once enjoyable activities may signify the encroachment of AUD into various life domains
In examining the potential effects of race on GLP-1 M responsiveness, subjects self-identifying as Asian showed a lower average reduction in HbA1C compared to non-Asian subjects, indicating potentially less benefit from GLP-1 M treatment for glucose control in Asian populations (Tables 4 and 5, Fig